Clinical Trials on POAG

Total 44 results

BelkinVision
Singapore Eye Research Institute

Not yet recruiting

Direct Selective Laser Trabeculoplasty in a Ethnic Chinese Population (Zhuiguangzhe)

POAG
The University of Hong Kong

Active, not recruiting

Asia Glaucoma Registry

POAG

Hong Kong
Oertli Instrumente AG
University of Geneva, Switzerland

Unknown

High Frequency Deep Sclerotomy (HFDS) ab Interno a Combination Surgical Intervention Using Cataract Surgery to Lower IOP (HFDS_abinterno)

Glaucoma | Cataract | POAG

Germany, Switzerland, Egypt, India
New World Medical, Inc.

Not yet recruiting

Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects With Open-Angle Glaucoma

POAG

Costa Rica, Honduras, Mexico
Centre Hospitalier Universitaire, Amiens
Central Hospital Saint Quentin

Recruiting

Efficacy and Safety of iStent Inject and Inject W in the Management of Primary Open-angle Glaucoma (EII)

POAG | MIGS

France
Transcend Medical, Inc.

Completed

Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy (DUETTE)

Primary Open Angle Glaucoma (POAG)
Glaukos Corporation

Completed

Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

Primary Open Angle Glaucoma (POAG)

Armenia
Glaukos Corporation

Completed

Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two iStents

Subjects With Primary Open-angle Glaucoma (POAG)

Armenia
Implandata Ophthalmic Products GmbH

Completed

Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG)

Primary Open Angle Glaucoma (POAG)

Germany
Glaukos Corporation

Terminated

iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications

Primary Open Angle Glaucoma (POAG)

Brazil
Glaukos Corporation

Completed

One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

Primary Open Angle Glaucoma (POAG)

Armenia
University Hospital, Grenoble

Not yet recruiting

Role of Peripheral Vision in Scene Perception (PERISCE) (PERISCE)

Primary Open-angle Glaucoma (POAG)
Alcon Research
Transcend Medical, Inc.

Completed

A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial (COMPASS-XT)

Primary Open Angle Glaucoma (POAG)

United States
Glaukos Corporation

Completed

A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal Stent

Subject With Primary Open-angle Glaucoma (POAG)

Armenia
Glaukos Corporation

Completed

Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStents

Subjects With Primary Open-angle Glaucoma (POAG)

Armenia
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure (PREDICOM)

Ocular Hypertension | Glaucoma, Primary Open Angle (POAG)

France
Transcend Medical, Inc.

Completed

Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery (COMPASS)

Cataract | Primary Open Angle Glaucoma (POAG)
Shire

Completed

Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma

Ocular Hypertension | Primary Open-angle Glaucoma (POAG)

United States
Maisonneuve-Rosemont Hospital

Recruiting

Visual Outcomes of Vivity in Patients With Well Controlled Glaucoma

Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Canada
Dr. David Yan
Allergan

Unknown

A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma

Primary Open Angle Glaucoma | Ocular Hypertension | POAG

Canada
Daniel Moore
Pfizer

Terminated

Safety Study of Latanoprost Slow Release Insert (Latanoprost SR)

Primary Open Angle Glaucoma (POAG) | Ocular Hypertension (OHT)

United States
Sensimed AG

Terminated

Intraocular Pressure (IOP) Patterns in Fast Versus Slow Visual Field (VF) Progression Patients

Primary Open-angle Glaucoma (POAG) Patient

United States
Inotek Pharmaceuticals Corporation

Completed

Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG

Ocular Hypertension (OHT) | Primary Open-Angle Glaucoma (POAG)

United States
Inotek Pharmaceuticals Corporation

Completed

A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma

Ocular Hypertension (OHT) | Primary Open-Angle Glaucoma (POAG)

United States
OcuTherix, Inc.

Terminated

Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension

Primary Open-angle Glaucoma (POAG) | Ocular Hypertension (OHT)

Philippines
Inotek Pharmaceuticals Corporation

Completed

Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma (MATrX-1)

Ocular Hypertension (OHT) | Primary Open-Angle Glaucoma (POAG)

United States
University Hospital Tuebingen
Alcon Research

Unknown

Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients (TRASCO)

Primary Open Angle Glaucoma (POAG)

Germany
Saint Alphonsus Regional Medical Center

Not yet recruiting

CardiaMend and Amiodarone for the Prevention of POAF

Atrial Fibrillation | POAF
Qlaris Bio, Inc.

Recruiting

Qlaris Phase 2 Study of QLS-111 in POAG and/or OHT Patients

Primary Open Angle Glaucoma of Both Eyes | Primary Open Angle Glaucoma (POAG) | Primary Open-Angle Glaucoma, Unspecified Eye | Ocular Hypertension (OHT)

United States
Institut für Pharmakologie und Präventive Medizin
Osypka AG

Recruiting

The DefiPace Study

Post-operative Atrial Fibrillation POAF

Austria, Germany
University of Michigan
Cherry Marketing Institute, Dewitt MI (USA)

Recruiting

Pilot-Tart Cherry, Mitral Transcriptome, and POAF Incidence

Post-operative Atrial Fibrillation (POAF)

United States
Alopexx Vaccine, LLC

Completed

A Study of AV0328 Administered to Healthy Adult Volunteers

PNAG-expressing Pathogenic Microbes Vaccine

United States
University of Michigan
California Table Grape Commission

Not yet recruiting

Anthocyanin-Rich Table Grape Powder for Prophylaxis of Post-Operative Atrial Fibrillation

Post-operative Atrial Fibrillation (POAF)

United States
Belkin Laser Ltd.

Completed

Evaluation of the Compatibility of Different Eye Lid Retractors to the Direct Selective Laser Trabeculoplasty (DSLT) Procedure

OAG - Open-Angle Glaucoma

Georgia
Transcend Medical, Inc.

Completed

Safety and Performance Study of the CyPass System Applier Model 241 (RePASS)

Open Angle Glaucoma (OAG)

Germany
The Emmes Company, LLC
United Mitochondrial Disease Foundation; PolG Foundation Mito Australia

Recruiting

Mitochondrial Video Assessment Source Material Study

PolG, Primary Mitochondrial Myopathy

United States
AbbVie

Recruiting

A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Implantation In Adult Participants With Open-Angle Glaucoma in China

Open-angle Glaucoma | OAG

China
Transcend Medical, Inc.

Completed

CyPass Clinical Experience Study (CyCLE)

Open Angle Glaucoma (OAG)

Spain, Austria, Bulgaria, Germany, Italy, Poland
Alcon Research

Completed

Travoprost Five Day Posology Study

Ocular Hypertension | Open-angle Glaucoma (OAG)

United States
Alcon Research

Completed

AL-54478 Proof of Concept Study

Open-angle Glaucoma (OAG) | Ocular Hypertension (OHT)
Qlaris Bio, Inc.

Recruiting

Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT Patients

Glaucoma | Open-angle Glaucoma (OAG) | Ocular Hypertension (OHT)

United States
University of California, San Diego
Bausch & Lomb Incorporated

Completed

Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity

OAG - Open-Angle Glaucoma | OHT - Ocular Hypertension

United States
University of California, San Diego
Aerie Pharmaceuticals

Withdrawn

Effects of Netarsudil and Timolol on Retinal Blood Vessel Density and Visual Acuity

OAG - Open-Angle Glaucoma | OHT - Ocular Hypertension
Ono Pharma USA Inc

Completed

Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma

Ocular Hypertension (OHT) | Mild Open Angle-glaucoma (OAG)

United States

Clinical Trials on POAG

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations